Table 3.
SMR and an AER stratified according to age category and time since first diagnosis. SMR is also stratified according to gender
Gender | Age category (years) | Duration category (years) | Total | ||||
0–29 | 30–49 | 50–69 | 70–99 | 0–9 | 10+ | ||
Male | |||||||
Observed | 8 | 12 | 63 | 113 | 104 | 92 | 196 |
Expected | 1.33 | 6.18 | 40.35 | 96.74 | 89.13 | 55.48 | 144.6 |
SMR | 6.01 | 1.94 | 1.56 | 1.17 | 1.17 | 1.66 | 1.36 |
95% CI | (3.00 to 12.01) | (1.10 to 3.43) | (1.22 to 2.00) | (0.97 to 1.40) | (0.96 to 1.41) | (1.35 to 2.03) | (1.18 to 1.56) |
Female | |||||||
Observed | 2 | 15 | 21 | 61 | 53 | 47 | 99 |
Expected | 0.43 | 2.49 | 15.68 | 53.57 | 44.3 | 27.86 | 72.16 |
SMR | 4.66 | 6.04 | 1.34 | 1.14 | 1.17 | 1.69 | 1.37 |
95% CI | (1.17 to 18.63) | (3.64 to 10.01) | (0.87 to 2.05) | (0.89 to 1.46) | (0.89 to 1.54) | (1.27 to 2.25) | (1.14 to 1.68) |
Total | |||||||
Observed | 10 | 27 | 84 | 174 | 156 | 139 | 295 |
Expected | 1.76 | 8.66 | 56.03 | 150.31 | 134.43 | 83.34 | 216.76 |
SMR | 5.68 | 3.12 | 1.50 | 1.16 | 1.17 | 1.67 | 1.36 |
95% CI | (3.06 to 10.55) | (2.14 to 4.55) | (1.21 to 1.86) | (1.00 to 1.34) | (1.00 to 1.37) | (1.41 to 1.97) | (1.21 to 1.53) |
Risk time (years) | 3992.02 | 4667.34 | 4963.88 | 2325.02 | 10 524.5 | 5423.77 | 15 948.27 |
AER/1000 years | 2.06 | 3.93 | 5.63 | 10.19 | 2.14 | 10.26 | 4.91 |
95% CI | (0.51 to 3.62) | (1.75 to 6.11) | (2.02 to 9.25) | (−0.93 to 21.31) | (−0.18 to 4.47) | (6.00 to 14.52) | (2.79 to 7.02) |
AER, absolute excess rate; SMR, standardised mortality ratio.